Sientra, Inc., a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery launched the Viality lipoaspirate wash system at the Beauty Through Science meeting in NYC this past Saturday. This product will be commercially available in the United States beginning in Q1 of 2023. Fat transfer, a procedure used to relocate fat from one area of the body to another where volume is desired, has increased in popularity in recent years and is used in both br

ApoQlar, a German medical technology company, today announced it has received FDA 510 Class II clearance for VSI HoloMedicine, a pioneering mixed reality software device enabling surgeons to plan complex procedures using the power of immersive 3D holographic technology. With this clearance, the USA becomes the 30th country for apoQlar to receive medical certification in. apoQlar will extend its distribution of VSI HoloMedicine in the USA for clinical use through its subsidiary in Miami, Flori

The VEITH 2022 symposium witnessed a series of clinical data supporting the use of the sirolimus-coated balloon in the treatment of below-knee disease. Concept Medical Inc. hosted a luncheon symposium entitled "Sirolimus-Coated Balloon in the Treatment of PAD: Choice of the Future", which explored the utility of the sirolimus-coated balloon in the treatment of PAD. The session was chaired by Prof. Sahil Parikh , co-moderated by Prof. Edward Choke and Prof. Aloke Finn with interestin

TherapeuticsMD, Inc. an innovative, leading women’s healthcare company, today announced that it has entered into definitive agreements to license its products to an affiliate of Mayne Pharma Group Limited an ASX-listed specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals, for commercialization in the United States. In addition, TXMD has agreed to sell certain assets to Mayne Pharma to allow Mayne Pharma to commercialize the products.At closing of

Mindray a globMindray a global leader in providing advanced medical device solutions, today launches the mWear system, an all-new wearable patient monitoring solution that enables an efficient workflow to continually monitor patient conditions and deliver patient-centric care.With the increased shortages of beds and staff in today’s hospitals, postoperative al leader in providing advanced medical device solutions, today launches the mWear system, an all-new wearable patient monitoring s

Today, the National Comprehensive Cancer Network an alliance of leading cancer centers—hosted its annual NCCN Patient Advocacy Summit. This year's dialogue was focused on sexual orientation and gender identity (SOGI), and the many barriers that can prevent LGBTQ+ people with cancer from accessing high-quality care. The impact of homophobia, transphobia, and social determinants of health have been shown to result in worse outcomes for vulnerable populations, particul

Tivic Health Systems, Inc.a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced it has hired ALOM Technologies Corporation a leader in global supply chain product and service delivery programs, to manage product supply chain, assembly, and logistics.Headquartered in the U.S., ALOM will be the company’s 3rd party logistics (3PL) warehouse, fulfillment, and production partner responsible for storing, packaging, and shipping T

Carenet Health, a leading provider of 24/7 and on-demand patient engagement solutions, today announced it has acquired Stericycle Communication Solutions, an industry leader in patient engagement technology and solutions and a service of Stericycle, Inc. as part of its strategic vision to create a cohesive patient experience and provide better healthcare for all.The acquisition strengthens Carenet’s robust capabilities in the payer, healthcare services, and clinical arenas by adding pro

Masimo today announced the results of a randomized, prospective, double-blind, controlled trial published in the Journal of the College of Physicians and Surgeons Pakistan . In this study, Dr. Sukriye Akdag and his team from Marmara University in Istanbul assessed the impact of continuous, non-invasive hemoglobin monitoring with Masimo SpHb on the management of blood transfusions in adult patients undergoing major elective surgery, where blood loss of at least 20% is expected. The researchers

Liminatus Pharma LL , a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition Corp a publicly traded special purpose acquisitioncompany formed for the purpose of acquiring or merging with one or more businesses, today announced they have entered into a definitive business combination agreement. Upon closing of the transaction, the combined company will be renamed “Liminatus Pharma, Inc.”. The combined company’s com